BE644613A - - Google Patents
Info
- Publication number
- BE644613A BE644613A BE644613A BE644613A BE644613A BE 644613 A BE644613 A BE 644613A BE 644613 A BE644613 A BE 644613A BE 644613 A BE644613 A BE 644613A BE 644613 A BE644613 A BE 644613A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- penetration
- composition
- solution
- dimethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32915163A | 1963-12-09 | 1963-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE644613A true BE644613A (nl) | 1964-07-01 |
Family
ID=23284077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE644613A BE644613A (nl) | 1963-12-09 | 1964-03-02 |
Country Status (2)
Country | Link |
---|---|
BE (1) | BE644613A (nl) |
CA (1) | CA1005761A (nl) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3527864A (en) * | 1966-11-18 | 1970-09-08 | Procter & Gamble | Compositions for topical application to animal tissue and method of enhancing penetration thereof |
US3527863A (en) * | 1964-11-25 | 1970-09-08 | Brunswick Corp | Tissue infiltrant |
US3548052A (en) * | 1964-10-27 | 1970-12-15 | Canada Packers Ltd | Heparin compositions and methods of using same |
US3548057A (en) * | 1969-04-29 | 1970-12-15 | Merck & Co Inc | Topical administration of vitamin b12 |
FR2182935A1 (nl) * | 1972-04-05 | 1973-12-14 | Procter & Gamble |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1236029A (en) * | 1984-05-14 | 1988-05-03 | Edmund Sandborn | Pharmaceutical solutions comprising dimethyl sulfoxide |
-
1964
- 1964-03-02 BE BE644613A patent/BE644613A/fr unknown
-
1965
- 1965-12-14 CA CA947,803A patent/CA1005761A/en not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3548052A (en) * | 1964-10-27 | 1970-12-15 | Canada Packers Ltd | Heparin compositions and methods of using same |
US3527863A (en) * | 1964-11-25 | 1970-09-08 | Brunswick Corp | Tissue infiltrant |
US3527864A (en) * | 1966-11-18 | 1970-09-08 | Procter & Gamble | Compositions for topical application to animal tissue and method of enhancing penetration thereof |
US3548057A (en) * | 1969-04-29 | 1970-12-15 | Merck & Co Inc | Topical administration of vitamin b12 |
FR2182935A1 (nl) * | 1972-04-05 | 1973-12-14 | Procter & Gamble |
Also Published As
Publication number | Publication date |
---|---|
CA1005761A (en) | 1977-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bowie et al. | Differential response of chlamydial and ureaplasma-associated urethritis to sulphafurazole (sulfisoxazole) and aminocyclitols | |
DE69434121T2 (de) | Pharmazeutische zusammensetzung zur immunverstärkenden therapie | |
Ford et al. | Pityrosporum folliculitis and ketoconazole | |
Bayer et al. | Inhibitory Effect of Ethanol on Canine Exocrine Pancreatk Secretion | |
EP1283708A2 (fr) | Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant | |
BE644613A (nl) | ||
CA2080820C (fr) | Derives azoiques, compositions pharmaceutiques et desinfectantes les contenant et leurs utilisations | |
US4801444A (en) | Medicinal preparation for individual prevention of venereal diseases and treatment of urogenital trichomoniasis | |
Buzia¹ et al. | Antibacterial action of certain tretinoin and benzoyl peroxide liposomes. Case study | |
Cusini et al. | Primary cutaneous cryptococcosis in a patient with the acquired immunodeficiency syndrome | |
US3737552A (en) | Method of treating gonorrhea | |
Murray et al. | Disseminated histoplasmosis following long-term steroid therapy for reticulosarcoma | |
CN103561735B (zh) | 具有抗菌、抗溃疡和免疫调节作用的药物制剂 | |
JPH06239757A (ja) | 抗アレルギー剤 | |
De Koning et al. | Single 1 g dose of cefotaxime in the treatment of infections due to penicillinase-producing strains of Neisseria gonorrhoeae. | |
CH675684A5 (nl) | ||
Pentland et al. | Failure of ejaculation with indoramin. | |
EP1317922A1 (fr) | Preparation antipyretique renfermant du xylitol | |
JP2004099613A (ja) | 自己免疫疾患治療用ガノデルマルシダム胞子 | |
Pesigan et al. | Pararosaniline pamoate (CI-403-A) in the treatment of Schistosoma japonicum infection in the Philippines | |
KOLMER | Bismuth arsphenamine sulphonate (bismarsen) in the treatment of syphilis and of other spirochetic infections | |
RU2749481C1 (ru) | Способ терапии поверхностных микозов | |
RU2362554C2 (ru) | Регенерирующее противовоспалительное средство и способы лечения с помощью этого средства | |
Takashima et al. | Treatment of PUVA‐and Retinoid‐PUVA‐resistant Severe Psoriasis with Systemic Cyclosporin A | |
CN113679709A (zh) | 丁香脂素在制备防治糖尿病肾病药物中的应用 |